Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?

被引:0
作者
Ahmet Bilici
Bala Basak Oven Ustaalioglu
Mesut Seker
Nesrin Canpolat
Bulent Tekinsoy
Taflan Salepci
Mahmut Gumus
机构
[1] Dr. Lutfi Kirdar Kartal Education and Research Hospital,Department of Medical Oncology
[2] Kosuyolu Yuksek Ihtisas Education and Research Hospital,Department of Nuclear Medicine
[3] Medipol Hospital,Department of Radiology
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2010年 / 37卷
关键词
PET/CT; FDG; CT; Ovarian cancer; Recurrence; Clinical management;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1259 / 1269
页数:10
相关论文
共 238 条
[1]  
Bristow RE(2000)A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography Cancer 89 1532-1540
[2]  
Duska LR(2004)Cancer of the ovary N Engl J Med 351 2519-2529
[3]  
Lambrou NC(1999)Surgery during chemotherapy and at relapse of ovarian cancer Ann Oncol 10 3-7
[4]  
Fishman EK(1996)Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N Engl J Med 334 1-6
[5]  
O’Neill MJ(2004)PET-CT in recurrent ovarian cancer: initial observations Radiographics 24 209-223
[6]  
Trimble EL(1985)Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer Am J Obstet Gynecol 151 981-986
[7]  
Cannistra SA(1996)Use of CA 125 in follow-up of ovarian cancer Lancet 348 191-192
[8]  
Berek JS(1995)Computed tomography and second-look surgery in ovarian cancer patients. Correlation, actual role and limitations of CT scan Eur J Gynaecol Oncol 16 123-129
[9]  
Tropé C(1998)Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history Clin Imaging 22 364-370
[10]  
Vergote I(2000)Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer Eur J Gynaecol Oncol 21 599-602